Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Curtis Maier"'
Autor:
Susan B Laffan, Andrew S Thomson, Shing Mai, Cindy Fishman, Takahito Kambara, Kiran Nistala, James T Raymond, Shugui Chen, Thulasi Ramani, Laura Pageon, Rodd Polsky, Mark Watkins, Gemma Ottolangui, John R White, Curtis Maier, Michael Herdman, Gerben Bouma
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0231655 (2020)
Despite the potential for the chemokine class as therapeutic targets in immune mediated disease, success has been limited. Many chemokines can bind to multiple receptors and many receptors have multiple ligands, with few exceptions. One of those exce
Externí odkaz:
https://doaj.org/article/ee33790a5c0946eb8e5ea303f460bcc0
Autor:
Andrea Kiessling, Frederic Brouta, Wendy J. Freebern, Marlowe J. Schneidkraut, Timothy K. MacLachlan, Birgit Fogal, Shawn Jay Berens, Sven Kronenberg, Curtis Maier, Laura Andrews, Cris Kamperschroer, Danuta J. Herzyk, Nikki Marshall
Publikováno v:
Regulatory toxicology and pharmacology : RTP. 119
With the growth of monoclonal antibodies and other proteins as major modalities in the pharmaceutical industry, there has been an increase in pharmacology and toxicity testing of biotherapeutics in animals. Animals frequently mount an immune response
Autor:
Gemma Ottolangui, Curtis Maier, Shugui Chen, James T. Raymond, Rodd Polsky, Cindy E. Fishman, Michael Herdman, Takahito Kambara, John R. White, Thulasi Ramani, Laura Pageon, Susan B. Laffan, Shing Mai, Kiran Nistala, Andrew S. Thomson, Gerben Bouma, Mark S Watkins
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 4, p e0231655 (2020)
PLoS ONE, Vol 15, Iss 4, p e0231655 (2020)
Despite the potential for the chemokine class as therapeutic targets in immune mediated disease, success has been limited. Many chemokines can bind to multiple receptors and many receptors have multiple ligands, with few exceptions. One of those exce
Autor:
Steve Enoch, Kohji Aoyama, Janine Ezendam, Colin M. North, Antti Karjalainen, Susan M. Tarlo, Cynthia Graham, Connie L. Chen, Juergen Pauluhn, Erwin Ludo Roggen, Amber K. Goetz, Curtis Maier, MaryJane K. Selgrade, Jon A. Hotchkiss, Ian Kimber
Publikováno v:
Regulatory Toxicology and Pharmacology. 80:295-309
Respiratory tract sensitization can have significant acute and chronic health implications. While induction of respiratory sensitization is widely recognized for some chemicals, validated standard methods or frameworks for identifying and characteriz
Autor:
Helen G. Haggerty, Danuta J. Herzyk, Rafael Ponce, B.D. Preston, Curtis Maier, R.D. Mellon, Frank R. Brennan, Herve Lebrec, Cris Kamperschroer, D. Weinstock
Publikováno v:
Regulatory Toxicology and Pharmacology. 75:72-80
Profound immunosuppression (e.g., AIDS, transplant therapy) is epidemiologically associated with an increased cancer risk, and often with oncogenic viruses. It is currently unclear how broadly this association translates to therapeutics that modulate
Autor:
J. Larkin, Jean Shearin, P.B. Tran, F. Liu, Louis Elefante, Thomas Lohr, Yu Xue, Rachel E. Miller, Caroline Genell, Curtis Maier, Jui-Lan Su, Rosalie Matico, Anne-Marie Malfait, Christopher Matheny
Publikováno v:
Osteoarthritis and Cartilage. 23(8):1254-1266
Summary Objective/Method Aggrecanase activity, most notably ADAMTS-5, is implicated in pathogenic cartilage degradation. Selective monoclonal antibodies (mAbs) to both ADAMTS-5 and ADAMTS-4 were generated and in vitro , ex vivo and in vivo systems we
Autor:
Maggie Dempster, Marque Todd, Curtis Maier, Jessica Couch, Lise I. Loberg, Timothy K. MacLachlan, Jan Willem van der Laan, Shawn Heidel, Kathryn Chapman, Fiona Sewell
Publikováno v:
mAbs
The market for biotherapeutic monoclonal antibodies (mAbs) is large and is growing rapidly. However, attrition poses a significant challenge for the development of mAbs, and for biopharmaceuticals in general, with large associated costs in resource a
Autor:
Curtis Maier, James Green, Holly W. Smith, Dan Wierda, Gopi Shankar, Danuta J. Herzyk, Inge A. Ivens, Shalini Gupta, Leslie Abad, Lakshmi Amaravadi, Bonita Rup, Thomas Gelzleichter, Peter Thomas, Christopher Hurst, Rafael A. Ponce, Elizabeth R. Gore, Thomas T. Kawabata, Barbara Mounho
Publikováno v:
Regulatory Toxicology and Pharmacology. 54:164-182
An evaluation of potential antibody formation to biologic therapeutics during the course of nonclinical safety studies and its impact on the toxicity profile is expected under current regulatory guidance and is accepted standard practice. However, ap
Autor:
Bruce D. Freedman, Michael I. Kotlikoff, Katsuyuki Yui, Brian Hondowicz, Curtis Maier, Andrew D. Wells, Qing-Hua Liu, Laurence A. Turka, Bernd K. Fleischmann
Publikováno v:
The Journal of Experimental Medicine
Ionic signaling pathways, including voltage-dependent potassium (Kv) channels, are instrumental in antigen-mediated responses of peripheral T cells. However, how Kv channels cooperate with other signaling pathways involved in T cell activation and di
Autor:
Danuta J. Herzyk, Louis Elefante, Ho Yen Sen, Trulli Stephen H, Kyung O. Johanson, Robert B. Kirkpatrick, Randall K. Johnson, Zdenka Ludmila Jonak, Yi-Jiun Chen, Curtis Maier, Francis L. McCabe, Michael T. Lotze
Publikováno v:
Journal of Immunotherapy. 25:S20-S27
Interleukin (IL)-18 has profound antitumor activity when administered at high doses as a single agent for prolonged periods in BALB/c mice bearing late, well-established MOPC-315 tumors. Management with a qD x 27 schedule resulted in regression of tu